06 Nov, EOD - Indian

SENSEX 80378.13 (1.13)

Nifty 50 24484.05 (1.12)

Nifty Bank 52317.4 (0.21)

Nifty IT 42039.5 (3.99)

Nifty Midcap 100 57355.8 (2.21)

Nifty Next 50 71389.8 (2.28)

Nifty Pharma 22920.35 (1.14)

Nifty Smallcap 100 18906.1 (2.18)

06 Nov, EOD - Global

NIKKEI 225 39480.67 (2.61)

HANG SENG 20538.38 (-2.23)

S&P 5974 (0.06)

Login/Signup
LOGIN HERE
Cancel

Cipla Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 500087 | NSE Symbol : CIPLA | ISIN : INE059A01026 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
01-Oct-2024 29-Oct-2024 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2024. Unaudited financial results (standalone and consolidated) for the quarter and half year ended 30th September 2024 Outcome of Board meeting dated 29th October 2024 (As Per BSE Announcement Dated on: 29/10/2024)
03-Sep-2024 03-Sep-2024 Change in Directors Outcome of Board meeting held on 3rd September 2024 Change in Directors of the Company Corrigendum - Outcome of Board meeting held on 3rd September 2024 (As Per BSE Announcement Dated on 04.09.2024)
04-Jul-2024 26-Jul-2024 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2024. Outcome of the Board Meeting held on 26th July 2024 (As per BSE Announcement Dated on 26/07/2024)
05-Apr-2024 10-May-2024 Accounts CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve 1. Consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2024. 2. Recommend final dividend for the year ended 31st March 2024 if any. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Monday 1st April 2024 till Sunday 12th May 2024 (both days inclusive) for the purpose of financial results. Outcome of board meeting held on 10th May 2024 Appointment of Cost Auditor for FY 2024-25 (As Per BSE Announcement Dated on 10/05/2024)
03-Jan-2024 22-Jan-2024 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Pursuant to regulation 29 of listing regulations we wish to inform you that the meeting of the board of directors of the company will he held on Thursday 25th January 2024 interalia to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st december 2023. The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024 The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024 (As per BSE Announcement Dated on 20/01/2024) The Board of Directors of the company at its meeting held on 22nd Jan 2024, has approved unaudited consolidated and standalone financial results. (As Per BSE Announcement dated on 22.01.2024)
06-Nov-2023 06-Nov-2023 Others Intimation pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 regarding Slump Sale of Business Undertaking is enclosed.
04-Oct-2023 27-Oct-2023 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve Pursuant to Regulation 29 of Listing Regulations we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 27th October 2023 inter-alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2023. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Sunday 1st October 2023 till Sunday 29th October 2023 (both days inclusive) for the purpose of financial results. The Board of Directors of the company at its meeting held on 27th October 2023, has approved unaudited consolidated and standalone financial result. Please find the attached extract of the consolidated unaudited financial results for the quarter ended 30th September 2023 to be published in newspaper. (As Per BSE Announcement dated on 27.10.2023)
04-Jul-2023 26-Jul-2023 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2023. CIPLA LIMITED has informed BSE about Board Meeting to be held on 26 Jul 2023 to consider financial statements for the period ended June 2023. Financial results / Other business. The Board of Directors of the Company at its meeting held on today i.e. 26th July, 2023, has approved unaudited consolidated and standalone financial result. Please find the attached outcome of Board meeting held today i.e. 26th July, 2023. (As Per BSE Announcement dated on 26.07.2023) We wish to inform that, Board of directors of the Company at its meeting held on 26th July, 2023 has approved the changes in the Key Managerial Personnel (KMPs) authorised under Regulation 30(5) of the Listing Regulations with effect from 26th July 2023. The Contact details of the KMPs authourised under Regulation 30(5) of the listing regulations are enclosed. (As Per BSE Announcement Dated on 27.07.2023)
12-Apr-2023 12-May-2023 Accounts CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of Listing Regulations, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 12th May 2023 inter-alia to: 1. Consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2023. 2. Recommend final dividend for the year ended 31st March 2023, if any. In compliance with the provision of the Company''s Code of Conduct for Prevention of Insider Trading, the 'Trading Window'''' for dealing in the securities of the Company has been closed from Saturday, 1st April, 2023 up to Sunday, 14th May, 2023 (both days inclusive). Audited Results & Quarterly Results & Final Dividend (As Per BSE Bulletin dated on 12.04.2023) Please find the attached intimation letter dated 12th May 2023. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation dated 12th May 2023. In furtherance to our intimation dated 12th May 2023 under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the meeting of the Board of Directors which commenced today at 11.45 a.m. (IST) has concluded at 3.15 p.m. (IST). Please find enclosed letter dated 12th May 2023. In furtherance to our intimation dated 12th May 2023 under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the meeting of the Board of Directors which commenced today at 11.45 a.m. (IST) has concluded at 3.15 p.m. (IST). Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we hereby notify that Dr. Peter Mugyenyi, Independent Director of the Company has vide letter dated 12th May 2023 resigned from the position of Independent Director of the Company with effect from 13th May 2023. (As Per BSE Announcement Dated on 12.05.2023)
29-Dec-2022 25-Jan-2023 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2022. The Board of Directors of the Company at its meeting held today i.e., 25th January 2023, has inter-alia approved the unaudited financial results (standalone and consolidated) for the quarter and nine months ended 31st December 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed as follows: (1) Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards, for the quarter and nine months ended 31st December 2022; and (2) Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP, Statutory Auditor of the Company, for the quarter and nine months ended 31st December 2022. The meeting of the Board of Directors of the Company commenced at 10.30 a.m. (IST) and is still in progress. In furtherance to our intimation dated 25th January 2023 under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, w.r.t. the unaudited financial result (standalone and consolidated) for the quarter and nine months ended 31st December 2022, approved by the Board of Directors at its meeting held today, we hereby notify that said meeting of the Board of Directors which commenced today at 10.30 a.m. (IST) has concluded at 3.00 p.m. (IST). (As per BSE Announcement Dated on 25/01/2023)
11-Oct-2022 04-Nov-2022 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 4th November 2022 inter-alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2022. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company has been closed from Saturday 1st October 2022 till Sunday 6th November 2022 (both days inclusive) for the purpose of financial results. The Board of the Directors of the Company at its meeting held today i.e. 4th November 2022, has inter-alia approved the Unaudited Financial Results (standalone and consolidated) for the quarter & half year ended 30th September 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed as follows: (1) Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards for the quarter & half year ended 30th September 2022; and (2) Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP, Statutory Auditor of the Company, for the quarter & half year ended 30th September 2022. The meeting of the Board of Directors of the Company commenced at 10.30 a.m. IST and is still in progress. In furtherance to our intimation dated 4th November 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify the meeting of the Board of Directors which commenced today at 10.30 a.m. (IST) has concluded at 3.30 p.m. (IST). (As Per BSE Announcement dated on 04.11.2022)
16-Aug-2022 16-Aug-2022 Change in Other Executives The Board of Directors at its meeting held today i.e. August 16, 2022, has approved the appointment of Mr. Ashish Adukia as the Global Chief Financial Officer and Key Managerial Personnel of the Company.
08-Jul-2022 29-Jul-2022 Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2022. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company has been closed from Friday 1st July 2022 till Sunday 31st July 2022 (both days inclusive). The Board of the Directors of the Company at its meeting held today i.e. 29th July 2022, has inter-alia approved the Unaudited Financial Results (standalone and consolidated) for the quarter ended 30th June 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed as follows: (1) Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards for the quarter ended 30th June 2022; and (2) Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP, Statutory Auditor of the Company, for the quarter ended 30th June 2022. The meeting of the Board of Directors of the Company commenced at 12.15 p.m. 1ST and is still in progress. In furtherance to our intimation dated 29th July, 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors which commenced today at 12.15 p.m. (1ST) has concluded at 5.10 p.m. (1ST). In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we hereby notify that on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the shareholders at the ensuing Annual General Meeting, the Board of the Directors at its meeting held today i.e., on 29th July 2022, has appointed Dr. Mandar Purushottam Vaidya (DIN: 09690327) as an additional and independent director of the Company for p period of 5 years with effect from 29th July 2022 to 28th July 2027 (both days inclusive). (As per BSE Announcement Dated on 29/07/2022)
19-Apr-2022 10-May-2022 Dividend CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 10th May 2022 inter-alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31st March 2022 and recommendation of dividend if any. In compliance with the provision of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company has been closed from Friday 1st April 2022 up to Thursday 12th May 2022 (both days inclusive). In furtherance to our intimation dated 10th May, 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations Requirements) Regulations, 2015, the meeting of the Board of Directors which commenced today at 2.30 p.m. (IST) has concluded at 6.40 p.m. (IST). Please find enclosed letter dated 10th May 2022 In furtherance to our intimation dated 10th May, 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations Requirements) Regulations, 2015, the meeting of the Board of Directors which commenced today at 2.30 p.m. (IST) has concluded at 6.40 p.m. (IST). We wish to inform you that, the Board of Directors of the Company at its meeting held on 10th May 2022 has approved the changes in the Key Managerial Personnel (KMPs) authorized under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') with effect from 10th May 2022. The contact details of the KMPs authorized under Regulation 30(5) of the Listing Regulations are enclosed. (As Per NSE Announcement Dated on 10/05/2022)
30-Dec-2021 25-Jan-2022 Quarterly Results Quarterly Results In furtherance to our intimation dated 25th January 2022 under Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, w.r.t the unaudited financial results (standalone and consolidated) for the quarter and nine months ended 31st December, 2021, approved by the Board of Directors at its meeting held today, we hereby notify that the said Board meeting of the Company which commenced today at 2.30 p.m. (IST) has concluded at 6.35 p.m. (IST). Pursuant to the provisions of Regulation 30 of the SEBI Listing Regulations and further to the intimation dated 26th October 2021, we hereby notify that the Board of Directors of Cipla Limited ('the Company') at its meeting held today, i.e., 25th January, 2022 have inter alia, approved the transfer of the following undertakings as a going concern on a slump sale basis in the following manner: (i) India based US business undertaking ('Undertaking 1') to Cipla BioTec Limited, a wholly owned subsidiary of the Company ('Transferee Company 1 or CBL'); and (ii) Consumer business undertaking ('Undertaking 2') to Cipla Health Limited, wholly owned subsidiary of the Company ('Transferee 2 or CHL') as a going concern on a slump sale basis. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following: i. Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards for the quarter and nine months ended 31st December, 2021 as approved by the Board at its meeting held on 25th January, 2022; ii. Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP, Statutory Auditor of the Company, for the quarter and nine months ended 31st December, 2021. The meeting of the Board of Directors of the Company commenced at 02.30 p.m. (IST) and is still in progress. (As per BSE Announcement Dated on 25/01/2022) Update on intimation dated 25th January 2022 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements), Regulations 2015 ('Listing Regulations') (As Per BSE Announcement dated on 04.11.2022)
1 2